Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Seattle Genetics (SGEN)

2014-11-28@10:38:58 ET
Potential Seattle Genetics (SGEN) Trade Targets 4.38% Return (FBM)

2014-11-26@10:43:39 ET
Potential Seattle Genetics (SGEN) Trade Targets 4.96% Return (FBM)

2014-11-26@03:57:08 ET
Seattle Genetics appoints executive vice president of legal affairs (DTM)

2014-11-25@13:47:29 ET
Seattle Genetics Makes a Move: Down 2.1% (F77)

2014-11-25@12:23:46 ET
Seattle Genetics Crosses Below its 10-day MA (SGEN) (F78)

2014-11-24@11:15:44 ET
Seattle Genetics (SGEN) Trading Near $35.64 Support Level (FBM)

2014-11-21@10:01:08 ET
Seattle Genetics (SGEN) Trading Near $35.21 Support Level (FBM)

2014-11-20@12:06:50 ET
Buyers Accumulate Shares of Seattle Genetics, Up 1.4% (F77)

2014-11-20@08:12:14 ET
Analysis of Relative Performance in the Biotechnology Industry for Shares of BioCryst Pharmaceuticals (BCRX, INO, SGEN, MNKD, IMGN) (F70)

2014-11-19@08:10:11 ET
Best Relative Performance in the Biotechnology Industry Detected in Shares of BioCryst Pharmaceuticals (BCRX, SGEN, MNKD, IMGN, MNTA) (F70)

2014-11-18@09:01:36 ET
Seattle Genetics Names New General Counsel and Executive Vice President, Legal Affairs (BIZ)

2014-11-18@05:56:55 ET
Form 144: Filing to Sell 10000 Shares of Seattle Genetics Inc (SGEN) (VKR)

2014-11-18@03:50:00 ET
Seattle Genetics reports lower Q3 net loss, provides outlook for 2014 (DTM)

2014-11-17@14:38:10 ET
Earnings Look Back: Seattle Genetics Is Up 0.3% Since Reporting Quarterly Results 2 Weeks Ago (SGEN) (PSM)